Naturally occurring CD4+ CD25+ cells in modulating immune response to administered coagulation factor VIII in factor VIII-deficient mice

Haemophilia

Volumn 17, Issue 1, 2011, Pages 143-151

  Kallas, A ^a   Kuuse, S ^a   Maimets, T ^a   Pooga, M ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

CD4+ CD25+ cells; Factor VIII; Factor VIII antibodies; FVIII deficient mice; Haemophilia A

Indexed keywords

BLOOD CLOTTING FACTOR 8; HEMATOLOGIC AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; RECOMBINANT FACTOR 8; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL THERAPY; CONTROLLED STUDY; GENE; IMMUNE RESPONSE; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; FLOW CYTOMETRY; HEMOPHILIA A; MICE; MICE, 129 STRAIN; T-LYMPHOCYTES, REGULATORY;

EID: 79951898095     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02376.x     Document Type: Article

References (32)

1. Reding MT, Wu H, Krampf M et al. Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects. Thromb Haemost 2000; 84: 643-52.
2. Kamate C, Lenting PJ, Van den Berg HM, Mutis T. Depletion of CD4+/CD25 high regulatory T cells may enhance or uncover factor VIII-specific T-cell responses in healthy individuals. J Thromb Haemost 2007; 5: 611-3.
3. Madoiwa S, Yamauchi T, Kobayashi E et al. Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A. J Thromb Haemost 2009; 7: 811-24.
4. Su RJ, Epp A, Latchman Y, Bolgiano D, Pipe SW, Josephson NC. Suppression of FVIII inhibitor formation in hemophilic mice by delivery of transgene modified apoptotic fibroblasts. Mol Ther 2009; 18: 214-22.
5. Waters B, Qadura M, Burnett E et al. Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+ CD25+ -dependent mechanism and by shifting cytokine production to favor a Th1 response. Blood 2009; 113: 193-203.
6. Miao CH, Harmeling BR, Ziegler SF et al. CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice. Blood 2009; 114: 4034-44.
7. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3: 253-7.
8. Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009; 30: 626-35.
9. Mucida D, Cheroutre H. TGFbeta and retinoic acid intersect in immune-regulation. Cell Adh Migr 2007; 1: 142-4.
10. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-87.
11. Sakaguchi S, Sakaguchi N. Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol 2005; 24: 211-26.
12. Joetham A, Takeda K, Okamoto M et al. Antigen specificity is not required for modulation of lung allergic responses by naturally occurring regulatory T cells. J Immunol 2009; 183: 1821-7.
13. Morris GP, Brown NK, Kong YC. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun 2009; 33: 68-76.
14. Li J, Bracht M, Shang X et al. Ex vivo activated OVA specific and non-specific CD4+ CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses. Cell Immunol 2006; 241: 75-84.
15. Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost 1995; 73: 247-51.
16. Kohm AP, McMahon JS, Podojil JR et al. Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+ CD25+ T regulatory cells. J Immunol 2006; 176: 3301-5.
17. Sumoza-Toledo A, Eaton AD, Sarukhan A. Regulatory T cells inhibit protein kinase C{theta} recruitment to the immune synapse of naive T cells with the same antigen specificity. J Immunol 2006; 176: 5779-87.
18. Kleinclauss F, Perruche S, Masson E et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2006; 13: 41-52.
19. Liu T, Soong L, Liu G, Konig R, Chopra AK. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells. Biol Direct 2009; 4: 40.
20. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T cell receptor stimulation is TGF{beta}-dependent but does not confer a regulatory phenotype. Blood 2007; 110: 2983-90.
21. Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, et al. 1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183: 5458-67.
22. Mucida D, Park Y, Kim G et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317: 256-60.
23. Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol 2004; 173: 7259-68.
24. Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 2005; 115: 1923-33.
25. Barthlott T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003; 197: 451-60.
26. Almeida AR, Zaragoza B, Freitas AA. Competition controls the rate of transition between the peripheral pools of CD4+ CD25- and CD4+ CD25+ T cells. Int Immunol 2006; 18: 1607-13.
27. Fernandez I, Zeiser R, Karsunky H et al. CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. J Immunol 2007; 179: 2808-14.
28. Lal G, Zhang N, van der Touw W et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 2009; 182: 259-73.
29. Floess S, Freyer J, Siewert C et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007; 5: e38.
30. Reipert BM, Ahmad RU, Turecek PL, Schwarz HP. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A. Thromb Haemost 2000; 84: 826-32.
31. Skupsky J, Zhang AH, Su Y, Scott DW. A role for thrombin in the initiation of the immune response to therapeutic factor VIII. Blood 2009; 114: 4741-8.
32. Scharrer I, Neutzling O. Incidence of inhibitors in haemophiliacs. A review of the literature. Blood Coagul Fibrinolysis 1993; 4: 753-8.